Navin R Mahadevan Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2024	Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
1/2023	ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
1/2022	Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels.
1/2022	Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Navin R Mahadevan Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 01/2010
6	Bites and Stings (Sting) 01/2024 - 01/2020
6	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2022
2	Adenocarcinoma 02/2024 - 01/2010
2	Breast Neoplasms (Breast Cancer) 02/2013 - 06/2011
1	Disease Progression 02/2024
1	Multiple Hamartoma Syndrome (Cowden's Disease) 10/2023
1	Myofibroma 10/2023
1	Myopericytoma 10/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Neuroblastoma 10/2022
1	Mesothelioma 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 11/2017
1	Starvation 06/2017
1	Neoplasm Metastasis (Metastasis) 03/2012
1	Carcinogenesis 03/2012
1	Inflammation (Inflammations) 03/2012
1	Bacterial Infections (Bacterial Infection) 03/2012
1	Hypoxia (Hypoxemia) 03/2012
1	Lymphoma (Lymphomas) 01/2010

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
5	InterferonsIBA 01/2024 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2022
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2022
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	CollagenIBA 10/2023 - 06/2023
2	Endoplasmic Reticulum Chaperone BiPIBA 06/2017 - 04/2011
2	NoxaeIBA 03/2012 - 04/2011
2	Lipocalin-2IBA 03/2012 - 06/2011
2	CytokinesIBA 04/2011 - 01/2010
1	Programmed Cell Death 1 ReceptorIBA 05/2024
1	Exonucleases (3' 5' Exonuclease)IBA 05/2024
1	Enhancer of Zeste Homolog 2 ProteinIBA 02/2024
1	Histone MethyltransferasesIBA 02/2024
1	exodeoxyribonuclease IIBA 01/2024
1	Nucleic AcidsIBA 01/2024
1	Aurora Kinase AIBA 11/2023
1	B7-H1 AntigenIBA 11/2023
1	TensinsIBA 10/2023
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 10/2023
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2023
1	PlasticsIBA 06/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Pemetrexed (MTA)FDA Link 11/2022
1	LigandsIBA 10/2022
1	Adenosine Monophosphate (AMP)IBA 10/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Histone DemethylasesIBA 01/2022
1	MesothelinIBA 01/2022
1	Chemotactic FactorsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	E-SelectinIBA 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 11/2017
1	Mitogen-Activated Protein KinasesIBA 11/2017
1	Proteasome InhibitorsIBA 06/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2017
1	Bortezomib (Velcade)FDA Link 06/2017
1	VaccinesIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 02/2013
1	SiderophoresIBA 03/2012
1	IronIBA 03/2012
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 06/2011
1	Glucose (Dextrose)FDA LinkGeneric 06/2011
1	ThapsigarginIBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2011
1	Conditioned Culture MediaIBA 04/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	InterleukinsIBA 01/2010
1	Interleukin-23 Subunit p19IBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010

Therapy/Procedure

6	Therapeutics 02/2024 - 03/2012
5	Immunotherapy 11/2023 - 01/2021
1	Castration 02/2024
1	Drug Therapy (Chemotherapy) 06/2017